Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection

被引:17
作者
Hedstrom, Anna Karin [1 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
multiple sclerosis; Epstein-Barr virus; infectious mononucleosis; human leukocyte antigen; vitamin D; sun exposure; smoking; obesity; VITAMIN-D STATUS; BODY-MASS INDEX; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NATURAL-KILLER-CELLS; T-CELLS; IMMUNE-RESPONSE; CYTOMEGALOVIRUS-SEROPOSITIVITY; ANTIBODY-TITERS; TOBACCO-SMOKE; SUN EXPOSURE;
D O I
10.3389/fimmu.2023.1212676
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Compelling evidence indicates that Epstein Barr virus (EBV) infection is a prerequisite for multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV infection, genetic predisposition, and various environmental and lifestyle factors that negatively affect immune control of the infection. Evidence of gene-environment interactions and epigenetic modifications triggered by environmental factors in genetically susceptible individuals supports this view. This review gives a short introduction to EBV and host immunity and discusses evidence indicating EBV as a prerequisite for MS. The role of genetic and environmental risk factors, and their interactions, in MS pathogenesis is reviewed and put in the context of EBV infection. Finally, possible preventive measures are discussed based on the findings presented.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis?
    Hassani, Asma
    Khan, Gulfaraz
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [42] Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis
    Laederach, Fabienne
    Muenz, Christian
    CELLS, 2022, 11 (17)
  • [43] Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies
    Fernandez-Menendez, Santiago
    Fernandez-Moran, Marta
    Fernandez-Vega, Ivan
    Perez-Alvarez, Angel
    Villafani-Echazu, Javier
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 361 : 213 - 219
  • [44] The implications of Epstein-Barr virus in multiple sclerosis - A review
    Munch, M
    Hvas, J
    Christensen, T
    MollerLarsen, A
    Haahr, S
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 : 59 - 64
  • [45] Epstein-Barr virus and multiple sclerosis: interaction with HLA
    E Sundqvist
    P Sundström
    M Lindén
    A K Hedström
    F Aloisi
    J Hillert
    I Kockum
    L Alfredsson
    T Olsson
    Genes & Immunity, 2012, 13 : 14 - 20
  • [46] Increased risk of multiple sclerosis after late Epstein-Barr virus infection - A historical prospective study
    Haahr, S
    KochHenriksen, N
    MollerLarsen, A
    Eriksen, LS
    Andersen, HMK
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 : 70 - 75
  • [47] Primary Epstein-Barr virus infection
    Dunmire, Samantha K.
    Verghese, Priya S.
    Balfour, Henry H., Jr.
    JOURNAL OF CLINICAL VIROLOGY, 2018, 102 : 84 - 92
  • [48] Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis
    Bistrom, M.
    Jons, D.
    Engdahl, E.
    Gustafsson, R.
    Huang, J.
    Brenner, N.
    Butt, J.
    Alonso-Magdalena, L.
    Gunnarsson, M.
    Vrethem, M.
    Bender, N.
    Waterboer, T.
    Granasen, G.
    Olsson, T.
    Kockum, I.
    Andersen, O.
    Fogdell-Hahn, A.
    Sundstrom, Peter
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (02) : 579 - 586
  • [49] Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
    Bjornevik, Kjetil
    Munz, Christian
    Cohen, Jeffrey, I
    Ascherio, Alberto
    NATURE REVIEWS NEUROLOGY, 2023, 19 (03) : 160 - 171
  • [50] Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis
    Lindsey, J. W.
    Hatfield, L. M.
    Crawford, M. P.
    Patel, S.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (02) : 153 - 158